BioNTech (NASDAQ: BNTX) got a substantial boost from the pandemic and its mRNA vaccine, developed with Pfizer (NYSE: PFE). The stock has seen a substantial correction since then due to slowing COVID s

BioNTech Stock Crumbles After 2023 Outlook Misses By Almost $3 Billion

09:28am, Monday, 27'th Mar 2023

BioNTech said Monday it expects roughly $5.4 billion in sales of its Covid shot this year, missing views and leading BNTX stock to tumble. The post BioNTech Stock Crumbles After 2023 Outlook Misses By

BioNTech Stock Is Falling. Blame the Covid Vaccine Outlook.

07:19am, Monday, 27'th Mar 2023

The German biotech that partnered with Pfizer to develop a Covid-19 vaccine expects fewer vaccinations and lowered levels of boosting this year.

BioNTech stock falls as earnings beat expectations, but show falling demand for COVID-19 vaccines

07:02am, Monday, 27'th Mar 2023

The U.S.-listed shares of BioNTech SE BNTX, -0.92% fell 2.7% in premarket expectations, as profit and revenue beat expectations but fell from a year ago due to lower demand for COVID-19 vaccines, and

The Cream Of The Crop: 5 Biotech Stocks That Outrank 91% Of All Stocks

12:33pm, Friday, 24'th Mar 2023

The top five biotech stocks today have several commonalities: strong ratings. Some also show promising charts and are Tech Leaders.

7 Blue-Chip Stocks Sitting in the Sweet Spot

01:56pm, Thursday, 23'rd Mar 2023

Although blue-chip stocks often carry a reputation for being lumbering giants that might not kill your portfolio but certainly won't do it any favors, specific stalwarts can get the business done. In

Earnings Previews: BioNTech, Carnival

10:08am, Thursday, 23'rd Mar 2023

In early trading Thursday, the Dow Jones industrials were up 0.25%, the S&P 500 up 0.62% and the Nasdaq up 1.21%.

BioNTech inks deal with OncoC4 to develop cancer treatments

08:35am, Monday, 20'th Mar 2023

BioNTech SE BNTX, -1.76% will pay $200 million to the privately held OncoC4 Inc. as part of a deal to develop and commercialize OncoC4's monoclonal antibody treatment that is being tested in several c

7 Stocks Set to Soar When the Market Recovers

11:16pm, Thursday, 16'th Mar 2023

While time in the market generally beats out timing the market, it's understandable that some investors may want to hold off on looking for stocks to buy. After all, equities continue to digest the su

FDA updates authorization of BioNTech, Pfizer's bivalent booster for young children

08:39am, Wednesday, 15'th Mar 2023

The Food and Drug Administration on Tuesday said children between the ages of 6 months and 5 years old can now get a booster dose of BioNTech BNTX and Pfizer's PFE COVID-19 bivalent vaccine. The third

BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023

07:45am, Monday, 13'th Mar 2023

MAINZ, Germany , March 13, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the full year and fourth quarter 2022 on Mo

Roquefort develops a fifth programme using a technology pioneer by Moderna and BioNTech

02:34am, Wednesday, 08'th Mar 2023

Roquefort Therapeutics PLC (LSE:ROQ, OTCQB:ROQAF) said has developed a new platform of potential anti-cancer messenger RNA (mRNA) therapeutics, expanding the company's portfolio to five in-house progr

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by